The mammographic correlations of a new immunohistochemical classification of invasive breast cancer

Clinical Radiology

Volumn 63, Issue 11, 2008, Pages 1228-1235

  Taneja, S ^a   Evans, A J ^a   Rakha, E A ^b   Green, A R ^b   Ball, G ^c   Ellis, I O ^b  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^b NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^c NOTTINGHAM TRENT UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROTEIN P53; UVOMORULIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER GRADING; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TISSUE MICROARRAY;

ADULT; AGED; BREAST NEOPLASMS; CADHERINS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MAMMOGRAPHY; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; RECEPTOR, ERBB-2; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 53049096675     PISSN: 00099260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crad.2008.06.006     Document Type: Article

References (42)

1. Carter C.L., Allen C., and Henson D.E. Relation of tumour size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63 (1989) 181-187
2. Galea M.H., Blamey R.W., Elston C.W., et al. The Nottingham prognostic index in primary breast cancer. Breast Cancer Res Treat 22 (1992) 207-219
3. Blamey R.W., Ellis I.O., Pinder S.E., et al. Improvement in case survival in breast cancer across the prognostic spectrum: effect on the Nottingham prognostic index. Eur J Cancer 43 (2007) 1548-1555
4. Lee A.H.S., Pinder S.E., Macmillan R.D., et al. Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma. Eur J Cancer 42 (2006) 357-362
5. Perou C.M., Sorlie T., Eisen M.B., et al. Molecular portraits of human breast tumours. Nature 406 (2000) 747-752
6. Sorlie T., Perou C.M., Tibshirani R., et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98 (2001) 10869-10874
7. Sorlie T., Tibshirani R., Parker J., et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A 100 (2003) 8418-8423
8. Tabar L., Duffy S.W., Vitak B., et al. The natural history of breast carcinomas: what have we learned from screening?. Cancer 86 (1999) 449-462
9. Ellis I.O., Galea M., Broughton N., et al. Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up. Histopathology 20 (1992) 479-489
10. Elston C.W., and Ellis I.O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19 (1991) 403-410
11. Elston C.W., Ellis I.O., and Pinder S.E. Pathological prognostic factors in breast cancer. Crit Rev Oncol Hematol 31 (1999) 209-223
12. Pinder S.E., Murray S., Ellis I.O., et al. The importance of the histologic grade of invasive breast carcinoma and response to chemotherapy. Cancer 83 (1998) 1529-1539
13. Haybittle J.L., Blamey R.W., Elston C.W., et al. A prognostic index in primary breast cancer. Br J Cancer 45 (1982) 361-366
14. Evans A.J., Rakha E.A., Pinder S.E., et al. Basal phenotype: a powerful prognostic factor in small screen-detected invasive breast cancer with long-term follow-up. J Med Screen 14 (2007) 210-214
15. Rakha E.A., and Ellis I.O. An overview of assessment of prognostic and predictive factors in breast cancer needle core biopsy specimens. J Clin Pathol 60 (2007) 1300-1306
16. Beckmann M.W., Niederacher D., Schnurch H.G., et al. Multistep carcinogenesis of breast cancer and tumour heterogeneity. J Mol Med 75 (1997) 429-439
17. Klauber-DeMore N. Tumor biology of breast cancer in young women. Breast Dis 23 (2005-2006) 9-15
18. Kononen J., Bubendorf L., Kallioniemi A., et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4 (1998) 844-847
19. Abd El-Rehim D.M., Ball G., Pinder S.E., et al. High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses. Int J Cancer 116 (2005) 340-350
20. Likaki-Karatza E., Ravazoula P., Androutsopoulos G., et al. Correlation of mammographic appearance and molecular prognostic factors in high-grade breast carcinomas. Eur J Gynaecol Oncol 27 (2006) 39-41
21. Tabar L., Tony Chen H.H., Amy Yen M.F., et al. Mammographic tumor features can predict long-term outcomes reliably in women with 1-14 mm invasive breast carcinoma. Cancer 101 (2004) 1745-1759
22. Alexander M.C., Yankaskas B.C., and Biesemier K.W. Association of stellate mammographic pattern with survival in small invasive breast tumors. AJR Am J Roentgenol 187 (2006) 29-37
23. Evans A.J., Pinder S.E., James J.J., et al. Is mammographic spiculation an independent, good prognostic factor in screening-detected invasive breast cancer. AJR Am J Roentgenol 187 (2006) 1377-1380
24. Thurfjell E., Thurfjell M.G., and Lindgren A. Mammographic finding as predictor of survival in 1-9 mm invasive breast cancers. Worse prognosis for cases presenting as calcifications alone. Breast Cancer Res Treat 67 (2001) 177-180
25. Peacock C., Given-Wilson R.M., and Duffy S.W. Mammographic casting-type calcification associated with small screen-detected invasive breast cancers: is this a reliable prognostic indicator?. Clin Radiol 59 (2004) 165-170
26. James J.J., Evans A.J., Pinder S.E., et al. Is the presence of mammographic comedo calcification really a prognostic factor for small screen-detected invasive breast cancers?. Clin Radiol 58 (2003) 54-62
27. Ainge G.R., Choplin R.H., Bechtold R.E., et al. Relationship between mammographic features and hormone receptor content in patients with breast cancer. South Med J 82 (1989) 1506-1511
28. Nielsen N.S., and Poulsen H.S. Relation between mammographic findings and hormonal receptor content in breast cancer. AJR Am J Roentgenol 145 (1985) 501-504
29. Broberg A., Glas U., Gustafsson S.A., et al. Relationship between mammographic pattern and estrogen receptor content in breast cancer. Breast Cancer Res Treat 3 (1983) 201-207
30. Ciatto S., Morrone O., Catarzi A., et al. Breast cancer: reliability of mammographic appearance as a predictor of hormone receptor status. Radiology 182 (1992) 805-808
31. Hinton C.P., Roebuck E.J., Williams M.R., et al. Mammographic parenchymal patterns value as a predictor of hormone dependency and survival in breast cancer. AJR Am J Roentgenol 144 (1985) 1103-1107
32. De Nunzio M.C., Evans A.J., Pinder S.E., et al. Correlations between the mammographic features of screen detected invasive breast cancer and pathological prognostic factors. Breast 6 (1997) 146-149
33. Karamouzis M.V., Likaki-Karatza E., Ravazoula P., et al. Non-palpable breast carcinomas: correlation of mammographically detected malignant-appearing microcalcifications and molecular prognostic factors. Int J Cancer 102 (2002) 86-90
34. Rakha E.A., El-Rehim D.A., Paish C., et al. Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance. Eur J Cancer 42 (2006) 3149-3156
35. Abd El-Rehim D.M., Pinder S.E., et al. Expression of luminal and basal cytokeratins in human breast carcinoma. J Pathol 203 (2004) 661-671
36. Yamashita H., Nishio M., Toyama T., et al. Coexistence of HER2 over-expression and p53 protein accumulation is a strong prognostic molecular marker in breast cancer. Breast Cancer Res 6 (2004) R24-R30
37. Seery L.T., Knowlden J.M., Gee J.M., et al. BRCA1 expression levels predict distant metastasis of sporadic breast cancers. Int J Cancer 84 (1999) 258-262
38. Takei H., Iino Y., Horiguchi J., et al. Immunohistochemical analysis of cytokeratin #8 as a prognostic factor in invasive breast carcinoma. Anticancer Res 15 (1995) 1101-1105
39. Malzahn K., Mitze M., Thoenes M., et al. Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomas. Virchows Arch 433 (1998) 119-129
40. Goffin J.R., Chappuis P.O., Begin L.R., et al. Impact of germline BRCA1 mutations and overexpression of p53 on prognosis and response to treatment following breast carcinoma: 10-year follow-up data. Cancer 97 (2003) 527-536
41. Alizadeh A.A., Ross D.T., Perou C.M., et al. Towards a novel classification of human malignancies based on gene expression patterns. J Pathol 195 (2001) 41-52
42. Luck A.A., Evans A.J., James J.J., et al. Breast carcinoma with basal phenotype: mammographic findings. AJR Am J Roentgenol 191 (2008) 346-351